BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36742310)

  • 1. A bacterial outer membrane vesicle-based click vaccine elicits potent immune response against
    Sun J; Lin X; He Y; Zhang B; Zhou N; Huang JD
    Front Immunol; 2023; 14():1088501. PubMed ID: 36742310
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The
    König E; Gagliardi A; Riedmiller I; Andretta C; Tomasi M; Irene C; Frattini L; Zanella I; Berti F; Grandi A; Caproni E; Fantappiè L; Grandi G
    Front Immunol; 2021; 12():752168. PubMed ID: 34819933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
    Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
    Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
    Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Display of Recombinant Proteins on Bacterial Outer Membrane Vesicles by Using Protein Ligation.
    van den Berg van Saparoea HB; Houben D; de Jonge MI; Jong WSP; Luirink J
    Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29439988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer Membrane Vesicles Derived from
    Tian H; Li B; Xu T; Yu H; Chen J; Yu H; Li S; Zeng L; Huang X; Liu Q
    Appl Environ Microbiol; 2021 Sep; 87(19):e0096821. PubMed ID: 34319809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated Salmonella typhimurium vaccines delivering SaEsxA and SaEsxB via type III secretion system confer protection against Staphylococcus aureus infection.
    Xu C; Zhang BZ; Lin Q; Deng J; Yu B; Arya S; Yuen KY; Huang JD
    BMC Infect Dis; 2018 Apr; 18(1):195. PubMed ID: 29699491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms.
    Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327437
    [No Abstract]   [Full Text] [Related]  

  • 10. Protective efficacy of Alum adjuvanted Amidase protein vaccine against Staphylococcus aureus infection in multiple mouse models.
    Suresh MK; Vasudevan AK; Biswas L; Biswas R
    J Appl Microbiol; 2022 Feb; 132(2):1422-1434. PubMed ID: 34487603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Vaccines for
    Dupont CD; Scully IL; Zimnisky RM; Monian B; Rossitto CP; O'Connell EB; Jansen KU; Anderson AS; Love JC
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135219
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of a vaccine against Staphylococcus aureus.
    Spellberg B; Daum R
    Semin Immunopathol; 2012 Mar; 34(2):335-48. PubMed ID: 22080194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the R domain of coagulase by active vaccination protects mice against lethal Staphylococcus aureus infection.
    Qian M; Zhao T; Li R; Yang Q; Yu R; Yin Y; Zai X; Li Y; Zhang J; Xu J; Chen W
    Microbes Infect; 2019; 21(3-4):163-169. PubMed ID: 30447395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus.
    Bagnoli F; Fontana MR; Soldaini E; Mishra RP; Fiaschi L; Cartocci E; Nardi-Dei V; Ruggiero P; Nosari S; De Falco MG; Lofano G; Marchi S; Galletti B; Mariotti P; Bacconi M; Torre A; Maccari S; Scarselli M; Rinaudo CD; Inoshima N; Savino S; Mori E; Rossi-Paccani S; Baudner B; Pallaoro M; Swennen E; Petracca R; Brettoni C; Liberatori S; Norais N; Monaci E; Bubeck Wardenburg J; Schneewind O; O'Hagan DT; Valiante NM; Bensi G; Bertholet S; De Gregorio E; Rappuoli R; Grandi G
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3680-5. PubMed ID: 25775551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens.
    Weyant KB; Oloyede A; Pal S; Liao J; Jesus MR; Jaroentomeechai T; Moeller TD; Hoang-Phou S; Gilmore SF; Singh R; Pan DC; Putnam D; Locher C; de la Maza LM; Coleman MA; DeLisa MP
    Nat Commun; 2023 Jan; 14(1):464. PubMed ID: 36709333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms.
    Miller LS; Fowler VG; Shukla SK; Rose WE; Proctor RA
    FEMS Microbiol Rev; 2020 Jan; 44(1):123-153. PubMed ID: 31841134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
    Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D
    Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369
    [No Abstract]   [Full Text] [Related]  

  • 19. Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection.
    Li P; Wang X; Sun X; Guan Z; Sun W
    mSphere; 2021 Oct; 6(5):e0069921. PubMed ID: 34612675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity.
    Choi SJ; Kim MH; Jeon J; Kim OY; Choi Y; Seo J; Hong SW; Lee WH; Jeon SG; Gho YS; Jee YK; Kim YK
    PLoS One; 2015; 10(9):e0136021. PubMed ID: 26333035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.